DHR GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Danaher Corp
Exchange: NYSESector: HealthcareIndustry: Diagnostics & Research
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com. © 2025 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 2025-14761 SOURCE Beckman Coulter Diagnostics
Did you know?
Price sits at 26% of its 52-week range.
Current Price
$191.12
+0.17%GoodMoat Value
$93.20
51.2% overvaluedProfile
Valuation (TTM)
Market Cap$135.00B
P/E37.35
EV$148.01B
P/B2.57
Shares Out706.35M
P/Sales5.49
Revenue$24.57B
EV/EBITDA21.38
Danaher Corp (DHR) Quality Analysis
DHR Profitability
Profitability trend analysis coming soon
DHR Growth
Growth trend analysis coming soon
DHR Financial Health
Financial health indicators coming soon
DHR Quality & Fundamental Analysis
Danaher Corp (DHR) is a Healthcare company in the Diagnostics & Research industry, listed on NYSE. This quality analysis page evaluates Danaher Corp's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Danaher Corp has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 14.71% and a return on equity (ROE) of 6.88%. Return on assets (ROA) stands at 4.33%.
The debt-to-equity ratio is 0.35, with a current ratio of 1.87. Operating margin is 19.09%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Danaher Corp is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.